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Abstract The current knowledge on biological protein acetyla-
tion is con¢ned to acetyl CoA-dependent acetylation of protein
catalyzed by speci¢c acetyl transferases and the non-enzymatic
acetylation of protein by acetylated xenobiotics such as aspirin.
We have discovered a membrane-bound enzyme catalyzing the
transfer of acetyl groups from the acetyl donor 7,8-diacetoxy-4-
methyl coumarin (DAMC) to glutathione S-transferase 3-3
(GST3-3), termed DAMC:protein transacetylase (TAase). The
puri¢ed enzyme was incubated with recombinant GST3-3 sub-
unit and DAMC, the modi¢ed protein was isolated by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) in gel digested with trypsin and the tryptic digest was
analyzed by mass spectrometry. The N-terminus and six lysines,
Lys-51, -82, -124, -181, -191 and -210, were found to be acety-
lated. The acetylation of GST3-3 described above was not ob-
served in the absence of either DAMC or TAase. These results
clearly establish the phenomenon of protein acetylation indepen-
dent of acetyl CoA catalyzed by a hitherto unknown enzyme
(TAase) utilizing a certain xenobiotic acetate (DAMC) as the
active acetyl donor.
6 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Acetyl donor; Protein acetylation;
Matrix-assisted laser desorption/ionization-time of £ight;
Transacetylase
1. Introduction
Transacetylase is the enzyme that transfers acetyl groups
from an acetylated compound, either a physiological metabo-
lite or a xenobiotic, to a receptor molecule. The familiar ex-
amples of such transacetylases are: (a) the enzyme catalyzing
the transfer of acetyl groups from platelet activating factor
(1-alkyl-2-acetyl phosphatidyl choline) to sphingosine [1,2] ;
(b) the enzymatic transfer of acetyl groups from N-acetyl-aryl-
amine to an amide [3]. Proteins are also the targets for enzy-
matic acetylation. The acetyl CoA-dependent enzymatic ace-
tylation of histones catalyzed by histone acetyl transferases
(HAT) stands prominent [4], but the knowledge on protein
acetylation independent of acetyl CoA is grossly con¢ned to
be non-enzymatic in nature. The most familiar example is the
observation of Sir John Vane that aspirin (acetyl salicylate)
acetylates cyclooxygenase resulting in inhibition of prosta-
glandin synthesis [5]. The enzymatic protein acetylation, inde-
pendent of acetyl CoA, has not been reported up to date. The
existence of a unique enzyme in rat liver microsomes that
catalyzes the transfer of acetyl groups from acetoxy xenobi-
otics to the speci¢c proteins was demonstrated for the ¢rst
time in our previous communications [6^8]. Acetoxy-4-methyl
coumarins were found to be versatile substrates for the en-
zyme termed DAMC:protein transacetylase (TAase) catalyz-
ing the possible acetylation of some speci¢c enzyme proteins
viz. cytochrome P-450, NADPH cytochrome c reductase and
glutathione S-transferase (GST) leading to modulation of
their catalytic activities. DAMC served as a model acetyl
group donor and GST as acetyl group receptor protein. A
convenient assay procedure was developed for TAase [8]
based on the irreversible inhibition of GST, the extent of
the inhibition of GST was considered as a measure of
DAMC:GST TAase activity. The TAase-mediated acetylation
of GST3-3 (isoform of GST) reported here unravels the hith-
erto unknown phenomenon of protein acetylation indepen-
dent of acetyl CoA. In addition, TAase-mediated acetylation
would amount to protein modi¢cation and hence the selective
speci¢city of acetylated drug may be utilized to target-desired
protein resulting in the expression of desired pharmacological
activity.
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2. Materials and methods
2.1. Demonstration of acetylation of GST by matrix-assisted laser
desorption/ionization-time of £ight (MALDI-TOF) mass
spectrometry (MS)
The reaction mixture containing TAase (50 Wg), recombinant
GST3-3 isoform (50 Wg) and DAMC (200 WM) in 0.25 M potassium
phosphate bu¡er (pH 6.5) was incubated for 30 min at 37‡C and the
reaction was subjected to SDS^PAGE in order to separate modi¢ed
GST3-3 from other contaminating proteins. The reaction mixture with
DMSO served as the control. The gel plugs (modi¢ed and unmodi¢ed
GST3-3) were separately washed and treated with dithiothreitol
(DTT) and iodoacetamide to alkylate the cysteine residues present
in the proteins. After reduction and alkylation, the gel plugs were
incubated with sequence grade trypsin overnight [9]. The peptide mix-
ture obtained after trypsin digestion was diluted four times with ma-
trix 2,5-dihydroxy benzoic acid (20 mg/ml) in 1:1 acetonitrile/0.1%
TFA v/v 1 Wl of the mix, and deposited on a MALDI target and
allowed to dry in order to perform MALDI-TOF MS analysis using
Bruker Bi£ex III MALDI-TOF mass spectrometer (Bruker Daltonics,
Bremen, Germany) equipped with a nitrogen laser emitting pulsed
ultraviolet light at 337 nm and operated in a re£ectrone mode. Ex-
ternal linear calibration was achieved using a mixture of angiotensin
II, substance P, bombesin adrenocorticotropic hormone (fragment 18^
39) and somatostatin (all from Sigma Chemical Company). Spectra
were acquired in the positive ion mode and the signal was accumu-
lated and averaged over 100^200 shots.
2.2. Liquid chromatography (LC)/MS/MS
LC/MS/MS measurements were conducted on an LCQ DECA
(Thermoquest, San Jose, CA, USA) using a conventional ESI source
in positive ion mode detection. The spray voltage was set at 3.8 kV
and the heated capillary temperature at 300‡C. The eluent £ow of 25
Wl/min was provided by an Eldex micro LC (separations). Analyses
were conducted on a 15 cmU800 Wm i.d. column packed with 5 Wm
spherisorb C18 reverse phase material (LC Packings, Amsterdam, The
Netherlands). The injection volume was 10 Wl. Gradient elution was
performed by using the following mobile phases: A: 10 mM ammo-
nium acetate in 0.1% HCOOH (v/v); B: 10 mM ammonium acetate in
0.15% HCOOH (v/v) and 80% acetonitrile (v/v). Gradient: from 5 to
30% B in 25 min, from 30 to 60% B in 10 min, from 60 to 100% B in
5 min, down to 5% B again in 2 min. Two full-scan (ranged m/z 200^
2000) LC-MS runs were initially acquired for modi¢ed and non-modi-
¢ed GST. Potentially acetylated peptides previously detected by
MALDI-TOF experiments were found back in LC-MS total ion cur-
rent (TIC) of the modi¢ed GST as singly or doubly protonated mol-
ecules, though their signal intensity in full-scan MS was rather weak
compared to other peptides present in the digest mixture. A second
LC-MS experiment with acquisition windows was designed in order to
perform MS/MS on these seven potentially acetylated peptides. In this
second LC-MS experiment, the mass spectrometer program was
switched to MS/MS mode in correspondence to the retention time
of the above-mentioned peaks. Precursor ions were selected with win-
dow of 2.5 m/z. The facilities for MALDI-TOF and LC/MS estab-
lished at TNO Voeding, Zeist (The Netherlands) were utilized.
3. Results
The enzyme TAase was puri¢ed from liver microsome of
the bu¡alo. The puri¢ed enzyme preparation had a molecular
weight of 63 kDa. In order to establish the TAase-catalyzed
acetylation of GST by DAMC as acetyl donor, the recombi-
nant GST3-3 was used as a model protein substrate. GST3-3
was incubated for 30 min with DAMC and TAase under the
conditions of the assay described in Section 2. The reaction
mixture was subjected to SDS^PAGE in order to separate
GST3-3 from the TAase. The subunit of GST3-3 considered
for MS analysis was devoid of any contaminating proteins,
which were removed by SDS^PAGE. The tryptic peptides
were extracted from the gel pieces and the unfractionated
tryptic digest was analyzed by MALDI-TOF MS. The pre-
dicted tryptic peptides were identi¢ed using Mascot Search
Engine (www.matrixscience.com). The peptide maps so ob-
tained covered 97% of the GST3-3 sequence. By overlaying
MALDI peptide maps of modi¢ed and control GST, seven
new peaks, corresponding to potentially acetylated peptides,
were detected in the modi¢ed map. The mass values of each of
them 42 kDa higher than the theoretical mass of native GST
tryptic peptides were 1290.68 (T110) ; 2107.15 (T5067);
1566.87 (T8293); 931.54 (T122128) ; 1721.85 (T173186);
763.33 (T187192) and 1203.77 (T202217), strongly suggesting
acetylation. CID spectra obtained were of good quality. Ace-
tylation at several points in the GST sequence was suggested
by MALDI, but ¢nal con¢rmation was possible by the appli-
cation of micro (W)LC/MS/MS. Tryptic peptides originated
from in-gel digestion of the modi¢ed GST were separated
by microbore reversed phase liquid chromatography
(RPLC), and peptides of interest were fragmented in an ion
trap mass spectrometer in order to get structural information
and to pinpoint amino acid modi¢cations. CID spectra were
obtained for seven peptides and two examples are shown in
Fig. 2A and B. By examining the fragmentation pattern and
by comparing experimental and predicted values for MS/MS
ions, the identity of the seven acetylated GST tryptic peptides
could be con¢rmed. The N-terminal proline and the six ly-
sines, Lys-51, -82, -124, -181, -191 and -210, were found ace-
tylated.
4. Discussion
Our perception of acetyl CoA-independent acetylation of
proteins had its origin in our investigations on the mechanism
Fig. 1. TAase-catalyzed reaction.
C
Fig. 2. A: MS/MS spectrum of peptide T110 ; m/z 1290.5 [(M+H)þ, 100]. B: MS/MS spectrum of peptide T187192 ; m/z 763.3 [(M+H)þ, 100].
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of biochemical action of DAMC. We had earlier demon-
strated the remarkable inhibitory action of DAMC on several
microsomal cytochrome P-450-linked mixed function oxidases
(MFO) catalyzing a£atoxin B1-epoxidation, dealkylation of
alkylated resoru¢ns [6,10] and toxicokinetics of benzene [11].
The irreversible inhibition of MFO mediated by DAMC was
in contrast to the action of classical inhibitors of cytochrome
P-450 [12^15] in that DAMC needed no prior oxidative me-
tabolism. Also, the potent inhibition of cytochrome P-450-
linked MFO by DAMC was nearly abolished by thiol block-
ing agents such as p-hydroxy mercuribenzoate (PHMB) and
iodoacetamide [8]. Such observations strongly connoted the
existence of a new enzyme in microsomes, termed DAM-
C:protein transacetylase (TAase) catalyzing the transfer of
acetyl groups of DAMC to the apoprotein of cytochrome
P-450 resulting in the mechanism-based inhibition of MFO.
Further investigations revealed that two other enzyme pro-
teins were possibly modi¢ed by TAase-catalyzed action of
DAMC. Accordingly, the hyperbolic activation of NADPH
cytochrome c reductase and the mechanism-based inhibition
of GST were recorded [7,8]. The irreversible inhibition of
cytosolic GST caused by incubation of DAMC with bu¡alo
liver microsomes served as the basis of an elegant assay pro-
cedure for TAase [8] and with this assay preliminary charac-
terization of TAase was carried out. TAase exhibited hyper-
bolic kinetics; Km and Vmax values obtained by varying
DAMC or GST concentration highlighted the nature of
TAase-catalyzed reaction as bimolecular. The formation of
7,8-dihydroxy-4-methyl coumarin (DHMC), a product of the
TAase-catalyzed reaction (Fig. 1), was identi¢ed by us [8,10].
The convincing biochemical reasoning outlined above pointed
out the existence of a new enzyme, TAase. Nevertheless, the
hard-core evidence to this e¡ect in terms of protein (GST)
acetylation per se, amounting to the demonstration of the
other product (acetylated GST) of the TAase-catalyzed reac-
tion was essential. The realization of this objective necessi-
tated in the ¢rst place the puri¢cation of TAase and the pu-
ri¢ed preparation of TAase was utilized to study the
acetylation of GST by DAMC. Puri¢ed TAase from bu¡alo
liver microsomes catalyzed the acetylation of GST3-3 by
DAMC. The well-established mass spectrometric methods
were used to identify the sites. N-terminal proline and six
lysines in GST3-3 were found to be acetylated. The acetyla-
tion catalyzed by TAase was found clearly distinct from the
acetylation of GST as a consequence of natural post-transla-
tional modi¢cation where N-terminal residue alone was modi-
¢ed.
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